Doctor of Philosophy, Case Western Reserve University, 2025, Biochemistry
In eukaryotic cells, DNA is packaged into chromatin to facilitate organization within the nucleus. The basic unit of chromatin is the nucleosome, which consists of 147 base pairs of DNA wrapped around a histone octamer. The tails of histone proteins undergo various post-translational modifications, which can modify chromatin structure and/or influence gene expression. These dynamic histone modifications are orchestrated by numerous histone-modifying enzymes, including writers that deposit modifications and erasers that remove. This thesis reveals a novel mechanism underlying the non-canonical roles of these histone modifiers and their corresponding histone modifications in transcriptional regulation.
Specifically, the roles of LSD1, an H3K4me1/2 demethylase, are characterized, including its catalytically dependent and -independent functions in gene regulation and cell fate transition. Interestingly, the catalytic inactivation of LSD1 has only a mild impact on gene expression and cell fate transition, whereas LSD1-null cells exhibit global enhancer derepression and impaired cell fate transition. Moreover, LSD1 loss leads to increased H3K27 acetylation, enrichment of p300/CBP, an H3K27ac acetyltransferases, at enhancers, and transcriptional derepression, ultimately causing differentiation defects.
Previously, we identified the non-catalytic role of MLL4's N-terminal (NT) domain, an H3K4me1/2 methyltransferase, in regulating gene expression. However, its underlying mechanism is still elusive. Using the proximity labeling technique TurboID, I demonstrate the proximity and interaction between MLL4 NT and the H3K36 methyltransferase NSD1. Similar to the catalytic inactivation of NSD1, MLL4 deletion results in decreased H3K36me2 levels and increased H3K27me3 levels at MLL4-targeted enhancers, and co-regulated genes.
Finally, a synergistic role between H3K79me and H3K36me3 in transcriptional regulation is uncovered. Simultaneous catalytic inactivation of DOT1L, (open full item for complete abstract)
Committee: Kaixiang Cao Dr. (Advisor); Peter Harte Dr. (Committee Member); Hung-Ying Kao Dr. (Committee Member); Joseph Luna Dr. (Committee Chair)
Subjects: Biochemistry; Biomedical Research